Study of the neuroprotective effect of NT-3 dipeptide mimetics GTS-301 and GTS-302 on an experimental model of ischemic stroke
Animal research · 2026
- What was studied
- Rats with middle cerebral artery occlusion
- Main finding
- GTS-302 reduced infarct volume by 39% and improved the day-three neurological measure; GTS-301 was inactive in this experiment.
Study data at a glance
- Participants or experimental model
- Rats with middle cerebral artery occlusion
- Reported results
- GTS-302 reduced infarct volume by 39% and improved the day-three neurological measure; GTS-301 was inactive in this experiment.
Study limitations and source details
Study limitations
- Animal experiment, not evidence of benefit in human stroke.
- Full methods, sample size and risk of bias require review.
- This is a separate stroke paper; the correction to an earlier NT-3 withdrawal study does not resolve or invalidate this paper automatically.
Source details
Publisher-deposited abstract and metadata reviewed through Crossref; publisher website could not be retrieved.
Deposited abstract reviewed
Sources checked
Citation
D. M. Nikiforov, P. Yu. Povarnina, T. A. Gudasheva. Study of the neuroprotective effect of NT-3 dipeptide mimetics GTS-301 and GTS-302 on an experimental model of ischemic stroke Pharmacokinetics and Pharmacodynamics. 2026;(1):12–19
Study source ↗ · DOI 10.37489/2587-7836-2026-1-12-19 · Bibliography entry · Link to this summary